Thousands of people with multiple sclerosis in Syria face the risk of permanent disability and paralysis due to the ongoing shortage of medications for the disease in government hospitals.
The lack of essential preventative treatments has led to a sharp decline in patients' health. Specialists confirm that even a one-month interruption of treatment can result in irreversible neurological damage.
Several key medications have disappeared from the market, including Interferon beta 1a 44 and Interferon beta 30 injections, as well as intravenous treatments such as Rituximab 500 and Tereflonmid 14 tablets. Meanwhile, their prices have skyrocketed on the black market, making them unaffordable for most families.
Currently, only limited quantities of three types of these medications are available at Al-Mujtahid Hospital in Damascus, while other governorates are completely deprived of them.
According to patients and their families, the Ministry of Health has yet to respond to repeated appeals to secure the medications or provide alternative solutions, amidst the ongoing health and economic crisis.
Zaman al-Wasl
Zaman Al Wasl
Comments About This Article
Please fill the fields below.